BA
KRMD icon

Bard Associates’s KORU Medical Systems KRMD Stock Holding History

Bard Associates’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Hold
14,590
– – 0.01% 175
2026
Q1 		$63K Hold
14,590
– – 0.02% 162
2025
Q4 		$84.8K Hold
14,590
– – 0.02% 131
2025
Q3 		$55.9K Hold
14,590
– – 0.01% 153
2025
Q2 		$52.2K Sell
14,590
-11,320
-44% -$32.2K 0.02% 164
2025
Q1 		$65.8K Hold
25,910
– – 0.02% 165
2024
Q4 		$99.8K Hold
25,910
– – 0.03% 166
2024
Q3 		$70.7K Sell
25,910
-500
-2% -$1.23K 0.02% 165
2024
Q2 		$70K Hold
26,410
– – 0.03% 165
2024
Q1 		$62.3K Sell
26,410
-300
-1% -$644 0.02% 170
2023
Q4 		$65.6K Buy
26,710
+4,910
+23% +$11.7K 0.02% 165
2023
Q3 		$58.9K Hold
21,800
– – 0.02% 175
2023
Q2 		$75.2K Sell
21,800
-286
-1% -$1.12K 0.03% 173
2023
Q1 		$93.2K Hold
22,086
– – 0.04% 175
2022
Q4 		$78.8K Hold
22,086
– – 0.03% 178
2022
Q3 		$49K Buy
22,086
+500
+2% +$1.24K 0.02% 180
2022
Q2 		$55K Buy
21,586
+2,000
+10% +$4.85K 0.02% 176
2022
Q1 		$56K Buy
19,586
+286
+1% +$856 0.02% 180
2021
Q4 		$58K Hold
19,300
– – 0.02% 176
2021
Q3 		$55K Hold
19,300
– – 0.02% 172
2021
Q2 		$89K Hold
19,300
– – 0.03% 168
2021
Q1 		$68K Buy
+19,300
New +$83.6K 0.02% 152
2020
Q3 		– Sell
-10,000
Closed -$90K – 157
2020
Q2 		$90K Sell
10,000
-1,850
-16% -$18.7K 0.05% 140
2020
Q1 		$89K Hold
11,850
– – 0.07% 137
2019
Q4 		$77K Buy
+11,850
New +$57.8K 0.04% 153

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Bard Associates's KRMD Position: Q2 2026 in Review

Bard Associates held its KORU Medical Systems (KRMD) position steady in Q2 2026 at 14,590 shares worth $61.3K. The position accounts for 0.01% of the portfolio, ranked #175.

Bard Associates first reported a position in KRMD in Q4 2019 and has held it in 25 quarters since. The position peaked at $99.8K in Q4 2024. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Bard Associates held 14,590 shares of KORU Medical Systems worth $61.3K as of Q2 2026.
  • Bard Associates left its KORU Medical Systems share count unchanged in Q2 2026.
  • KORU Medical Systems made up 0.01% of Bard Associates's portfolio in Q2 2026, its #175 holding.
  • Bard Associates first reported a position in KORU Medical Systems in Q4 2019 and has held it in 25 quarters since.
  • Bard Associates's KORU Medical Systems position peaked at $99.8K in Q4 2024.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.